These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1039 related articles for article (PubMed ID: 9121257)

  • 1. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.
    Poynard T; Bedossa P; Opolon P
    Lancet; 1997 Mar; 349(9055):825-32. PubMed ID: 9121257
    [TBL] [Abstract][Full Text] [Related]  

  • 2.  Natural history of hepatitis C virus infection in a cohort of asymptomatic post-transfused subjects.
    Reggiardo MV; Fay F; Tanno M; García-Camacho G; Bottaso O; Ferretti S; Godoy A; Guerrita C; Paez M; Tanno F; Ruffinengo O; Benetti S; García Borrás SE; Rossi MC; Vorobioff J; Bessone F; Tanno H
    Ann Hepatol; 2012; 11(5):658-66. PubMed ID: 22947526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group.
    Benhamou Y; Bochet M; Di Martino V; Charlotte F; Azria F; Coutellier A; Vidaud M; Bricaire F; Opolon P; Katlama C; Poynard T
    Hepatology; 1999 Oct; 30(4):1054-8. PubMed ID: 10498659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
    Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. There is no difference in hepatic fibrosis rates of patients infected with hepatitis C virus and those co-infected with HIV.
    Souza AR; Tovo CV; Mattos AA; Chaves S
    Braz J Med Biol Res; 2008 Mar; 41(3):223-8. PubMed ID: 18176724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying the superior measure of rapid fibrosis for predicting premature cirrhosis after liver transplantation for hepatitis C.
    Howell J; Sawhney R; Angus P; Fink M; Jones R; Wang BZ; Visvanathan K; Crowley P; Gow P
    Transpl Infect Dis; 2013 Dec; 15(6):588-99. PubMed ID: 24028328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study.
    Ryder SD; Irving WL; Jones DA; Neal KR; Underwood JC;
    Gut; 2004 Mar; 53(3):451-5. PubMed ID: 14960533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of host-related factors on the intensity of liver fibrosis in patients with chronic hepatitis C virus infection.
    Costa LB; Ferraz ML; Perez RM; Ferreira AS; Matos CA; Lanzoni VP; Silva AE
    Braz J Infect Dis; 2002 Oct; 6(5):219-24. PubMed ID: 12495603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrosis progression in interferon treatment-naive Chinese plasma donors with chronic hepatitis C for 20 years: a cohort study.
    Li JF; Liu S; Ren F; Liu M; Wu HL; Chen Y; Zou HB; Bai L; Li Y; Zheng SJ; Duan ZP
    Int J Infect Dis; 2014 Oct; 27():49-53. PubMed ID: 25168642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study.
    Wright M; Goldin R; Fabre A; Lloyd J; Thomas H; Trepo C; Pradat P; Thursz M;
    Gut; 2003 Apr; 52(4):574-9. PubMed ID: 12631672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of common risk factors of fibrosis progression in chronic hepatitis C.
    Rüeger S; Bochud PY; Dufour JF; Müllhaupt B; Semela D; Heim MH; Moradpour D; Cerny A; Malinverni R; Booth DR; Suppiah V; George J; Argiro L; Halfon P; Bourlière M; Talal AH; Jacobson IM; Patin E; Nalpas B; Poynard T; Pol S; Abel L; Kutalik Z; Negro F
    Gut; 2015 Oct; 64(10):1605-15. PubMed ID: 25214320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Historical features are poor predictors of liver fibrosis in Canadian patients with chronic hepatitis C.
    Myers RP; Hilsden RJ; Lee SS
    J Viral Hepat; 2001 Jul; 8(4):249-55. PubMed ID: 11454175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High proportions of liver fibrosis and cirrhosis in an ageing population of people who use drugs in Amsterdam, The Netherlands.
    van Santen DK; Schim van der Loeff MF; Cartier van Dissel J; Martens JPD; van der Valk M; Prins M
    Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1168-1176. PubMed ID: 30028776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group.
    Sobesky R; Mathurin P; Charlotte F; Moussalli J; Olivi M; Vidaud M; Ratziu V; Opolon P; Poynard T
    Gastroenterology; 1999 Feb; 116(2):378-86. PubMed ID: 9922319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection.
    Westin J; Lagging LM; Spak F; Aires N; Svensson E; Lindh M; Dhillon AP; Norkrans G; Wejstål R
    J Viral Hepat; 2002 May; 9(3):235-41. PubMed ID: 12010513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infection.
    Marabita F; Aghemo A; De Nicola S; Rumi MG; Cheroni C; Scavelli R; Crimi M; Soffredini R; Abrignani S; De Francesco R; Colombo M
    Hepatology; 2011 Oct; 54(4):1127-34. PubMed ID: 21721028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrosis in chronic hepatitis C acquired in infancy: is it only a matter of time?
    Guido M; Bortolotti F; Leandro G; Jara P; Hierro L; Larrauri J; Barbera C; Giacchino R; Zancan L; Balli F; Crivellaro C; Cristina E; Pucci A; Rugge M
    Am J Gastroenterol; 2003 Mar; 98(3):660-3. PubMed ID: 12650803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity.
    Mathurin P; Moussalli J; Cadranel JF; Thibault V; Charlotte F; Dumouchel P; Cazier A; Huraux JM; Devergie B; Vidaud M; Opolon P; Poynard T
    Hepatology; 1998 Mar; 27(3):868-72. PubMed ID: 9500720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.